Type 2 immunity play a role in cancer initiation and progression, type 2 cytokines (e.g., IL-4 and IL-13) can inhibit the function of cytotoxic T cells, which limit the ability of T cell to eliminate cancer cells [15]. Here, IL13 is linked to cancer.